![]() |
|||
This chart gives a quick overview of what is normal and the conditions that result in high or low values. |
|||
| Possible Significance | |||
| Test | Normal Values | Increases | Decreases |
| Hematology | |||
| Aspartate aminotransferase (AST)—formerly called serum glutamic oxaloacetic transaminase (SGOT) | Men: 10-40 U/L Women: 9-25 U/L |
Myocardial infarction, cardiac surgery, hepatitis, cirrhosis, trauma, severe burns, progressive muscular dystrophy, infectious mononucleosis, acute renal failure | Uremia, chronic dialysis, ketoaci dosis |
| Bleeding time—indication of hemostatic efficiency | 1-9 min | Hemorrhagic purpura, acute leukemia, aplastic anemia, DIC, oral anticoagulant therapy | Uremia, chronic dialysis, ketoaci dosis |
| Hematocrit—volume of packed red blood cells/100 mL of blood | Men: 45% (40-50%) Women: 40% (38-47% |
Dehydration, polycythemia, congenital heart disease | Anemia, hemorrhage, leukemia, dietary deficiencies |
| Hemoglobin—oxygen-combining protein | Men: 13.5-18 g/dL Women: 12-16 g/dL |
Same as for Hematocrit | Same as for Hematocrit |
| Activated partial thromboplastin time (aPTT)— tests coagulation mechanism; stage I deficiencies |
aPTT: 25-41 | Deficiency of factors VIII, IX, X, XI, XII; anticoagulant therapy | Extensive cancer, DIC |
| Platelets—thrombocytes | 150,000-400,000/mm³ | Polycythemia vera, postsplenectomy, anemia | Leukemia, aplastic anemia, cirrhosis, multiple myeloma, chemotherapy |
| Prothrombin time—tests extrinsic clotting; stages II and III | 10-13 sec | Anticoagulant therapy, DIC, hepatic disease, malabsorption | Digitalis therapy, diuretic reaction, vitamin K therapy |
| Red blood cell count— number of circulating erythrocytes in 1 µL of whole blood |
Men: 4.5-6.2 million/µL Women: 4.2-5.4 million/ µL | Polycythemia vera, anoxia, dehydration | Lukemia, Hemorrhage, anemias, Hodgkin's |
| Sedimentation rate—speed at which red blood cells settle in uncoagu-lated blood | Men: 0-15 mm/hr Women: 0-20 mm/hr |
Acute bacterial infection, cancer, infectious disease, numerous inflammatory states | Polycythemia vera, sickle cell anemia |
| White blood cell count— number of leukocytes in 1 µL |
4.5-11 X 10³/µL | Leukemia, bacterial infection, severe sepsis | Viral infection, overwhelming bacterial infection, lupus erythematosus, antineoplastic chemotherapy, bone marrow depression |
| White blood cell differential—enumeration of individual leukocyte distribution | |||
| Neutrophils | 56% mean cell count 1800-7800/µL |
Bacterial infection, tumor, inflammation, stress, drug reaction, trauma, metabolic disorders | Acute viral infection, anorexia nervosa, radiation therapy, drug induced, alcoholic ingestion |
| Eosinophils | 2.7% cell count 0-450/µL |
Allergic disorder, parasitic infestation, eosinophilic leukemia | Acute or chronic stress; excess ACTH, cortisone, or epinephrine; endocrine disorder |
| Basophils | 25-100/(xL,or0-l% cell count 0-200/µL |
Myeloproliferative disease, leukemia | Anaphylactic reaction, hyperthyroidism, radiation therapy, infections, ovulation, pregnancy, aging |
| Lymphocytes | 20-40% cell count 1000-4800/µL |
Chronic lymphocytic leukemia, infectious mononucleosis, chronic bacterial infection, viral infection | Leukemia, systemic lupus erythematosus, immune deficiency disorders |
| Blood Chemistry | |||
| Alkaline phosphatase (ALP) |
32-92 U/L | Hyperparathyroidism, Paget's disease, cancer with bone metastasis, obstructive jaundice, cirrhosis, hepatitis A, rickets | Malnutrition, scurvy, celiac disease, chronic nephritis, hypothyroidism, cystic fibrosis |
| Amylase | 80-180 IU/L | Acute pancreatitis, mumps, duodenal ulcer, pancreatic cancer, perforated bowel, renal failure | Advanced chronic pancreatitis, chronic alcoholism |
| Bilirubin, serum | Direct: 0.0-0.4 mg/dL Indirect: 0.2-0.8 mg/dL Total: 0.3-1.0 mg/dL | Massive hemolysis, low-grade hemolytic disease, cirrhosis, obstructive liver disease, hepatitis, biliary obstruction, neonatal (physiological) jaundice | |
| Calcium, serum | 8.2-10.2 mg/dL | Hyperparathyroidism, multiple myeloma, bone metastasis, bone fracture, thiazide-diuretic reaction, milk-alkali syndrome |
Hypoparathyroidism, renal failure, pregnancy, massive transfusion |
| Carbon dioxide | 22-30 mEq/L | Emphysema, salicylate toxicity, vomiting | Starvation, diarrhea |
| Chloride, serum | 98-107 mEq/L | Hyperventilation, diabetes insipidus, | Heart failure, pyloric obstruction, hypoventilation, vomiting, chronic respiratory acidosis |
| Creatine, serum | Men: 0.7-1.3 mg/dL Women: 0.5-1.0 mg/dL |
Chronic glomerulonephritis, nephritis, heart failure, muscle disease | Debilitation, long-term corticosteroid therapy |
| Creatine kinase (CK) (creatine phosphoki-nase [CPK]) Isoenzymes |
Men: 17-148 IU/L Women: 10-79 IU/L |
Acute myocardial infarction, acute stroke, convulsions, surgery, muscular dystrophy, hypokalemia | Addison's disease |
| CPK-MM/CK-MM | 100% | Muscular dystrophy, delirium tremens, surgery, hypokalemia, crush injuries, hypothyroidism | |
| CPK/MB/CK-MB | 0.6% of total CPK | Acute myocardial infarction, cardiac defibrillation, myocarditis, cardiac ischemia | |
| CPK-BB/CK-BB | 0% | Pulmonary infarction, brain surgery, stroke, pulmonary embolism, seizures, intestinal ischemia | |
| Fibrinogen, serum | 0.2-0.4 g/lOOdL or 200-400 mg/dL |
Pneumonia, acute infection, nephrosis, rheumatoid arthritis | Cirrhosis, toxic liver necrosis, anemia, obstetric complications, DIC, advanced carcinoma |
| Glucose (fasting) | 60-110 mg/lOOmL (serum) | Acute stress, Cushing's syndrome, hyperthyroidism, acute or chronic pancreatitis, diabetes mellitus, hyperglycemia | Addison's disease, liver disease, reactive hypoglycemia, pituitary hypofunction |
| Glycosylated hemoglobin (HbAlc) |
4.0-7.0% | Newly diagnosed or poorly controlled diabetes mellitus | Iron deficiency anemia, chronic blood loss |
| Iron-binding capacity (total) | 218-385 g/dL | Lead poisoning, hepatic necrosis | |
| Lactic dehydrogenase (LDH) | 60-120 U/mL (Wacker Scale) 150-450 U/mL (Wroblewski) |
Myocardial infarction, pernicious anemia, chronic viral hepatitis, pneumonia, pulmonary emboli, stroke, renal tissue destruction, leukemia, non-Hodgkins lymphoma, shock, trauma | |
| LDH-1 |
17-27% |
||
| LDH-2 |
27-37% |
||
| LDH-3 |
18-25% |
||
| LDH-4 |
3-8% |
||
| LDH-5 |
6-16% |
||
| Lipids | |||
| Cholesterol (total serum)
Low-density lipoprotein (LDL) High-density lipoprotein (HDL) Triglycerides |
<200 mg/dL < 130 mg/dL 35-75 mg/dL 40-150 mg/100 mL |
Hypercholesterolemia, hyperlipidemia, myocardial infarction, uncontrolled diabetes mellitus, high-cholesterol diet, hypothyroidism, atherosclerosis, stress, glomerulonephritis (nephrotic stage), familial biliary obstruction | Malnutrition, cholesterol-lowering medication, anemia, liver disease, hyperthyroidism |
| Phosphorus, inorganic serum | 3.0-4.5 mg/dL | Chronic glomerular disease, hypoparathyroidism, milk-alkali syndrome, sarcoidosis | Hyperparathyroidism, rickets, osteomalacia, renal tubular necrosis, malabsorption syndrome, vitamin D deficiency |
| Potassium, serum | 3.5-5.0 mEq/L | Diabetic ketosis, renal failure, Addison's disease, excessive intake | Thiazide diuretics, Cushing's syndrome, cirrhosis with ascites, hyperaldosteronism, steroid therapy, malignant hypertension, poor dietary habits, chronic diarrhea, diaphoresis, renal tubular necrosis, malabsorption syndrome, vomiting |
| Protein, serum (albumin/globulin) |
Total: 6.4-8.3 g/dL Albumin: 3.5-5.0 g/dL Globulin: 2.8-4.4 g/dL |
Dehydration, multiple myeloma | Chronic liver disease, myeloproliferative disease, burns |
| Serum glutamic oxaloacetic transaminase (SGOT) |
|||
| Sodium, serum | 136-145 mEq/L | Increased intake, either orally or IV; Cushing's syndrome, excessive sweating, diabetes insipidus | Addison's disease, sodium-losing nephropathy, vomiting, diarrhea, fistulas, tube drainage, burns, renal insufficiency with acidosis, starvation with acidosis, paracentesis, thoracentesis, ascites, heart failure, SIADH |
| T3 uptake | 24-34% | Hyperthyroidism, thyroxine-binding globulin (TBG) deficiency | Hypothyroidism, pregnancy, TBG excess |
| Thyroxine | 5-12 M-g/dL | Hyperthyroidism, pregnancy | Hypothyroidism, renal failure |
| Urea nitrogen, serum (BUN) |
5-20 mg/dL | Acute or chronic renal failure, heart failure, obstructive uropathy, dehydration | Cirrhosis, malnutrition |
| Uric acid, serum | Men: 4.5-8 mg/dL Women: 2.5-6.2 mg/dL |
Gout, chronic renal failure, starvation, diuretic therapy | |
| Blood Gases | |||
| Bicarbonate (HC02;) | 21-28 mEq/L | Metabolic alkalosis | Metabolic acidosis |
| Carbon dioxide pressure (Pco2), whole blood, arterial |
35-45 mm Hg | Primary respiratory acidosis, loss of H+ through nasogastric suctioning or vomiting |
Primary respiratory alkalosis |
| Oxygen pressure (Po2), whole blood, arterial |
80-100 mm Hg | Oxygen administration in the absence of severe lung disease |
Chronic obstructive lung disease, severe pneumonia, pulmonary embolism, pulmonary edema, respiratory muscle disease |
| pH, serum |
7.35-7.45 | Metabolic alkalosis-alkali ingestion, respiratory alkalosis-hyperventilation |
Metabolic acidosis-ketoacidosis, shock, respiratory acidosis-alveolar hypoventilation |
| Immunodiagnostic Studies | |||
| Carcinoembryonic antigen | <2.5 ng/mL | Cancer of: colon, lung, metastatic breast, pancreas, stomach, prostate, ovary, bladder, limbs; also neuroblastoma, leukemias, osteogenic carcinoma; non-cancer conditions such as: hepatic cirrhosis, uremia, pancreatitis, colorectal, polyposis, peptic ulcer disease, ulcerative colitis, regional enteritis | |
| Urinalysis |
|||
| pH |
4.5-7.8 | Metabolic alkalosis | Metabolic acidosis |
| Specific gravity |
1.003-1.029 | Dehydration, pituitary tumor, hypotension |
Distal renal tubular disease, polycystic kidney disease, diabetes insipidus, overhydration |
| Glucose |
Negative | Diabetes mellitus |
|
| Protein |
Negative | Nephrosis, glomerulonephritis, lupus erythematosus |
|
| Casts |
0-0.4 hyaline casts per LPF | Nephrosis, glomerulonephritis, lupus erythematosus, infection |
|
| Red blood cells |
Negative | Renal calculi, hemorrhagic cystitis, tumors of the kidney |
|
| White blood cells |
Negative | Inflammation of the kidneys, ureters, or bladder |
|
| Color |
Normal yellow, clear | Abnormal: red to reddish brown—hema-turia; brown to brownish gray—biliru-binuria or urobilinuria; tea colored— possible obstructive jaundice |
Almost colorless: chronic kidney disease, diabetes insipidus, diabetes mellitus |
| Sodium |
40-220 mEq/L/24 hr | Salt-wasting renal disease, SIADH, dehydration
|
Heart failure, primary aldosteronism |
| Chloride |
110-250 mEq/24hr | Chronic obstructive lung disease, dehydration, salicylate toxicity |
Gastric suction, heart failure, emphysema |
| Potassium |
25-125 mEq/L/24 hr | Diuretic therapy |
Renal failure |
| Creatinine clearance |
90-139 mL/min | Renal disease | |
| Hydroxycorticosteroids |
2-10 mg/24 hr | Cushing's disease | Addison's disease |
| 17-Ketosteroids |
Men: 4.5-12 mg/24 hr Women: 2.5-10 mg/24 hr |
Hirsutism, adrenal hyperplasia |
Thyrotoxicosis, Addison's disease |
| Catecholamines (VMA) |
Epinephrine: <20 u.g/24 hr Norepinephrine: <100 u.g/24 hr |
Pheochromocytoma, severe anxiety, numerous medications |
|
| Urine Test |
|||
| Schilling test |
Excretion of 8-40% or more of test dose should appear in urine |
Gastrointestinal malabsorption, pernicious anemia |
|